This article explores the potential of topical timolol solution in improving the cosmetic appearance of surgical scars after Mohs micrographic surgery (MMS) with primary linear closure. The study involved 19 adult patients with nonmelanoma skin cancer who underwent MMS, with one-half of the wound treated with timolol solution and the other half treated with standard wound care. The results showed no statistically significant differences in scar cosmesis between the two groups, suggesting a limited role for timolol in improving the appearance of surgical scars in healthy patients. However, further research is needed to determine if timolol can be beneficial in cases of impaired or delayed wound healing. [Extracted from the article]